Lv3
256 积分 2025-11-25 加入
Evaluating the MAPA Medical Affairs Competency Framework: Insights from Amgen-Led Pilot Study in Australia, Japan and China
18小时前
待确认
Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era
1个月前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
3个月前
已完结
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
5个月前
已完结
Glycaemic management in diabetes: old and new approaches
5个月前
已完结
皖公网安备34019202002308
